Jennifer Moreno VA San Diego Healthcare System, San Diego, CA, USA.
Division of Gastroenterology, Department of Internal Medicine, University of California, San Diego, La Jolla, CA, USA.
Dig Dis Sci. 2023 Apr;68(4):1208-1217. doi: 10.1007/s10620-022-07685-4. Epub 2022 Sep 28.
Delays in colonoscopy work-up for red flag signs or symptoms of colorectal cancer (CRC) during the COVID-19 pandemic are not well characterized.
To examine colonoscopy uptake and time to colonoscopy after red flag diagnosis, before and during the COVID-19 pandemic.
Cohort study of adults ages 50-75 with iron deficiency anemia (IDA), hematochezia, or abnormal stool blood test receiving Veterans Health Administration (VHA) care from April 2019 to December 2020. Index date was first red flag diagnosis date, categorized into "pre" (April-December 2019) and "intra" (April-December 2020) policy implementation prioritizing diagnostic procedures, allowing for a 3-month "washout" (January-March 2020) period. Outcomes were colonoscopy completion and time to colonoscopy pre- vs. intra-COVID-19, examined using multivariable Cox models with hazard ratios (aHRs) and 95% confidence intervals (CIs).
There were 52,539 adults with red flag signs or symptoms (pre-COVID: 25,154; washout: 7527; intra-COVID: 19,858). Proportion completing colonoscopy was similar pre- vs. intra-COVID-19 (27.0% vs. 26.5%; p = 0.24). Median time to colonoscopy among colonoscopy completers was similar for pre- vs. intra-COVID-19 (46 vs. 42 days), but longer for individuals with IDA (60 vs. 49 days). There was no association between time period and colonoscopy completion (aHR: 0.99, 95% CI 0.95-1.03).
Colonoscopy work-up of CRC red flag signs and symptoms was not delayed within VHA during the COVID-19 pandemic, possibly due to VHA policies supporting prioritization and completion. Further work is needed to understand how COVID-19 policies on screening and surveillance impact CRC-related outcomes, and how to optimize colonoscopy completion after a red flag diagnosis.
在 COVID-19 大流行期间,对于结直肠癌(CRC)的红色标志症状或体征,延迟进行结肠镜检查的情况尚未得到充分描述。
在 COVID-19 大流行之前和期间,检查红色标志诊断后结肠镜检查的采用率和结肠镜检查的时间。
这是一项对年龄在 50-75 岁之间、患有缺铁性贫血(IDA)、血便或粪便潜血试验异常的成年人的队列研究,他们在退伍军人健康管理局(VHA)接受治疗。索引日期为首次出现红色标志诊断的日期,分为“前”(2019 年 4 月至 12 月)和“中”(2020 年 4 月至 12 月)政策实施期间,优先考虑诊断程序,并允许有 3 个月的“洗脱”期(2020 年 1 月至 3 月)。使用多变量 Cox 模型,使用风险比(aHR)和 95%置信区间(CI)检查结肠镜检查完成情况和结肠镜检查前与 COVID-19 之间的时间,作为结局。
共有 52539 名成年人出现红色标志体征或症状(前 COVID-19:25154 人;洗脱期:7527 人;中 COVID-19:19858 人)。结肠镜检查完成率在 COVID-19 前与 COVID-19 期间相似(27.0%与 26.5%;p=0.24)。在结肠镜检查完成者中,从红色标志诊断到结肠镜检查的中位时间在 COVID-19 前与 COVID-19 期间相似(46 天与 42 天),但 IDA 患者的时间较长(60 天与 49 天)。时间与结肠镜检查完成之间没有关联(aHR:0.99,95%CI 0.95-1.03)。
在 COVID-19 大流行期间,退伍军人健康管理局对结直肠癌的红色标志症状和体征的结肠镜检查工作并未延迟,这可能是由于退伍军人健康管理局的政策支持优先进行和完成检查。需要进一步研究了解 COVID-19 对筛查和监测的政策如何影响结直肠癌相关结果,以及如何优化红色标志诊断后的结肠镜检查完成率。